ArticleJMA journal2026
Eosinophilic Granulomatosis with Polyangiitis Presenting with Intermittent Claudication.
Article in JMA journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Intermittent claudication (IC), characterized by lower limb weakness and pain during walking that resolves with rest, is most commonly caused by lumbar spinal canal stenosis or peripheral arterial disease. We report a unique case of eosinophilic granulomatosis with polyangiitis (EGPA) presenting with IC. An 80-year-old woman presented with fever, muscle pain, muscle weakness, and IC. She had a history of bronchial asthma and allergic rhinitis. Laboratory tests revealed eosinophilia (4,212 /μL) and elevated creatine kinase levels (505 U/L). Magnetic resonance imaging (MRI) with short tau inversion recovery sequences demonstrated diffuse high-signal intensity across multiple skeletal muscles. A biopsy specimen of the right biceps brachii, taken from a high-signal area identified on MRI, showed inflammatory cell infiltration, primarily composed of eosinophils and lymphocytes in the blood vessel walls. The patient was diagnosed with EGPA-associated skeletal muscle involvement and treated with a moderate dose of glucocorticoids, resulting in significant clinical improvement. This case highlights that EGPA can present with IC, a rare manifestation of the disease, and underscores the diagnostic value of MRI in such cases. MRI may be a useful tool for localizing biopsy sites in patients with EGPA-related muscle damage. Clinicians should consider anti-neutrophil cytoplasmic antibody-associated vasculitis, including EGPA, in patients presenting with IC and systemic symptoms, and initiate early diagnostic and therapeutic interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.